Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
186.80    0.20 (0.11%)
Bid:
186.40
Ask:
186.60
Spread: 0.20 (0.107%)
Market Cap: £1.88b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Information to shareholders: statutory migration

13 Oct 2025 15:30

RNS Number : 1582D
B&M European Value Retail S.A.
13 October 2025
 

B&M European Value Retail S.A.

3, rue Gabriel Lippmann, L-5365 Munsbach,

Luxembourg.

 

13 October 2025

 

Information to shareholders in relation to Shareholding and Settlement Arrangements post Migration

B&M European Value Retail S.A. ("B&M Luxembourg" or the "Company") is pleased to provide further information to shareholders regarding the statutory Migration pursuant to which it will become, in law, B&M European Value Retail plc ("B&M Jersey"), a public limited company governed by the laws of Jersey and will cease to be a société anonyme ("S.A.") incorporated under the Laws of Luxembourg. 

Position regarding shareholdings prior to and following the Migration

Currently, the majority of the shareholders hold their shares either in the form of CREST Depository Interests ("CDIs") or indirectly through a broker, nominee or other custodian account with Euroclear. It is expected that the vast majority of the Company's existing shareholders will not need to take any action as a consequence of the Migration and that they will be able to continue to hold their interest in the Company's shares and to receive dividends in the same way as they do at the moment.

Dividend Mandates

Existing dividend mandates in respect of B&M Luxembourg shares will continue to be effective in relation to shares in B&M Jersey for all existing shareholders provided that any shareholders holding through CREST have enabled their CREST memorandum account to accept dividend payments via the CREST system in relation to their holdings.

Where can you find further information?

The Company has prepared an FAQ document for shareholders, which is available on the Company's website. Shareholders are advised to read the FAQ Document carefully to ensure that they understand the arrangements that will apply to them following the Migration being completed and the actions, if any, that they may wish to take.

Further updates on the Migration process

In anticipation of the Migration, an application will be made for admission of the B&M Jersey shares to the equity shares (commercial companies) category of the Official List of the Financial Conduct Authority and to trading on the main market for listed securities of the London Stock Exchange ("LSE") in place of the B&M Luxembourg shares, upon completion of the Migration (together, the "Admission"). Subject to certain regulatory approvals, it is expected that Admission and unconditional dealings in B&M Jersey shares will become effective after the publication of B&M Luxembourg's interim results on 13 November 2025 and prior to the end of this calendar year.

A new International Securities Identification Number ("ISIN"), JE00BVSYJW51, has been issued in respect of the B&M Jersey shares and will become effective upon the Migration being completed and Admission becoming effective.

A prospectus relating to the Admission is expected to be published by the Company shortly before Admission becomes effective. An announcement will be made at the relevant time via the LSE Regulatory News Service ("RNS") notifying shareholders that the prospectus has been published and that a copy of it is available for inspection on the Company's website.

Disclaimer and Important Information

The information set out in this announcement is for informational purposes only and is not, and is not to be construed as being, legal, business, financial or tax advice. If you are in any doubt the contents of this announcement or the action you should take or any potential tax consequences relating to any changes in the way in which you hold your Shares, you should consult your own appropriately authorised legal adviser, financial adviser or tax adviser.

If you hold your shares through a nominee, broker, custodian, trustee or in an ISA then you should also consult the relevant nominee, broker, custodian, trustee or ISA provider for assistance.

Enquiries

 

B&M European Value Retail S.A.

For further information please contact: +44 (0) 151 728 5400

Alexander Simpson

Group General Counsel

 

Andrew Orchard

Head of Investor Relations 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUOASRVOURAAA
Date   Source Headline
19th Nov 20244:52 pmRNSPricing of £250 Million Senior Secured Notes
18th Nov 20248:00 amRNSLaunch of £250 million Senior Secured Notes Offer
14th Nov 20247:00 amRNSFY25 Interim Results
31st Oct 20241:00 pmRNSTiming of Announcement of Interim Results
17th Oct 20243:00 pmRNSTR1: Notification of Major Holding in Company
4th Oct 20245:30 pmRNSDirector Declaration
30th Sep 20242:15 pmRNSTotal Voting Rights
13th Sep 20242:51 pmRNSGrant of Share Options to French Senior Management
12th Sep 20244:31 pmRNSPDMR Exercise of Share Options
3rd Sep 20242:15 pmRNSAppointment To Remuneration Committee
2nd Sep 20245:00 pmRNSTotal Voting Rights
29th Aug 20242:45 pmRNSPDMR Shareholding notification
12th Aug 20245:30 pmRNSGrant of Share Options
31st Jul 20245:29 pmRNSTotal Voting Rights
25th Jul 20245:45 pmRNSGrant of Options to Directors
23rd Jul 20242:57 pmRNSEGM Voting results announcement
23rd Jul 20242:15 pmRNSAGM 2024 Voting results announcement
16th Jul 20244:56 pmRNSBlock listing six monthly return
16th Jul 20247:00 amRNSQ1 FY25 Trading Update
19th Jun 20247:00 amRNSNotice of AGM and EGM
17th Jun 202410:00 amRNSGrant of Share Options
13th Jun 20244:50 pmRNSNotice of FY25 Q1 Trading Statement
7th Jun 20243:25 pmRNSPDMR Purchase of Shares
5th Jun 20247:05 amRNSAppointment of new Chair
5th Jun 20247:00 amRNSFY24 Preliminary Results
29th May 20242:30 pmRNSDirector Appointment & Results of OGM
24th Apr 20249:00 amRNSNotice of Ordinary General Meeting
16th Apr 20247:00 amRNSFY24 Post Close Trading Statement
4th Apr 202410:00 amRNSNotice of FY24 Post Close Trading Statement
22nd Mar 20249:00 amRNSBoard Appointment
8th Feb 20249:00 amRNSConfirmation of timing of FY24 Preliminary Results
1st Feb 20241:00 pmRNSMajor Shareholding in Company TR-1
30th Jan 20246:23 pmRNSHolding(s) in Company
24th Jan 202410:00 amRNSPDMR Purchase of Shares
23rd Jan 202412:00 pmRNSB&M Plans Chairman Succession
18th Jan 20242:46 pmRNSNotification of Major Shareholding
15th Jan 20242:20 pmRNSBlock listing Interim Review
9th Jan 20247:00 amRNSGolden Quarter - strong profitable growth
22nd Dec 202312:00 pmRNSCorrection: PDMR announcement
22nd Dec 20238:30 amRNSPost Stabilisation Notice
19th Dec 20239:04 amRNSPCA Notification
15th Dec 20239:00 amRNSNotification of major holdings
13th Dec 202312:10 pmRNSAnnouncement further to recent placing by SSA
30th Nov 20235:41 pmRNSChange of Registered Office
30th Nov 20234:01 pmRNSTotal Voting Rights
28th Nov 20239:22 amRNSDirector/PDMR Shareholding
27th Nov 20235:13 pmRNSNotice of FY24 Third Quarter Trading Statement
24th Nov 202310:35 amRNSPDMR Notification
21st Nov 202311:32 amRNSFinal Results of Tender Offer 3.625% Senior Notes
15th Nov 202310:11 amRNSTender Offer Indicative Maximum Acceptance Amount

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.